The University of Warwick research team led by Professor Nick Dale and Professor Elizabeth Jones from the University of Warwick’s Biological Sciences Department have published their work today, 25th October 2007, in Nature in a paper entitled Purine-mediated signaling triggers eye development.
The researchers were exploring whether release of ATP (an important signaling and energy carrying molecule) influenced the development of locomotion in frogs. Their experiment introduced molecules called ectoenzymes (normally found on the outside surface of cells) into frog embryos at one of the earliest stages when the frogs-to-be were just 8 cells in size. Three ectoenzymes were used: E-NTPDase1, E-NTPDase2 and E-NTPDase3. These ectoenzymes degrade ATP following its release from cells, however each version of the ectoenzyme has slightly different effects on this degradation.
The Warwick research team’s interest in locomotion was quickly eclipsed when they were amazed to find that the introduction of just one of the ectoenzemes (E-NTPDase2) had a dramatic affect on eye development in the tadpoles grown from these embryos. When introduced in cells that would form the head area of the tadpole multiple eyes appeared to be created. That was not the only surprise. When it was introduced in some cells that formed body parts outside the head area it could still produce an additional “ectopic” eye leading to tadpoles with an additional eye in their side, abdomen or even along their tail.
E-NTPDase2 quickly latches on to ATP converting it to ADP. This meant that where and when the researchers introduced E-NTPDase2 it led to nearby cells experiencing much higher levels of ADP. The Warwick team hypothesized that ATP must be released in a short burst from the location where the eye will develop so that it can be converted to ADP by E-NTPDase2, thereby providing the trigger for eye development. They were able to measure these short bursts of ATP using ATP sensors specially developed by Professor Dale. This is the first time researchers have been able to see and measure bursts of ATP so early in the development of living creatures.
The genes that initiate and direct eye development are well known and are collectively termed the Eye Field Transcription Factors” (EFTFs). One of the mysteries of the field is how these genes get turned on in the correct location and at the correct time to initiate eye development. The Warwick research shows that this short burst of ATP followed by accumulation of ADP is a key signal for initiating expression of the EFTFs and hence the development of the eye.
The discovery of this surprising new signal that literally switches on eye development it is not restricted to frogs. Mutations to the E-NTPDase2 gene on the human 9th chromosome is already known to cause severe head and eye defects. This suggests that this newly discovered mechanism for triggering eye development applies across a wide range of species.
This new understanding of how eye development is triggered will greatly assist researchers exploring stem cells connected to eye development and opens up an avenue of a research that could in just a few decades lead to the ability to produce an “eye in a dish”.
About the Research
Professor Elizabeth Jones: (link to embed this video)
Professor Nick Dale: (link to embed this video)
Dr Karine Masse: (link to embed this video)
Lab Shots: (link to embed this video)
Notes for editors:
The University of Warwick is consistently ranked in the top ten of UK universities in the national newspaper league tables and is ranked 5th among the UK's 100 universities for quality of research.
The Wellcome Trust is the largest charity in the UK. It funds innovative biomedical research, in the UK and internationally, spending around £500 million each year to support the brightest scientists with the best ideas. The Wellcome Trust supports public debate about biomedical research and its impact on health and wellbeing. http://www.wellcome.ac.uk
Video interviews are available for broadcasters. Please contact Peter Dunn for more information.
For further information please contact:
Professor Nicholas Dale,
Ted Pridgeon Professor of Neuroscience
University of Warwick Tel: +44 (0)24 7652 3729
Professor Elizabeth A. Jones
University of Warwick Tel: +44 (0)24 7652 3061
Peter Dunn, Press and Media Relations Manager, Communications Office,
University House University of Warwick, Coventry CV4 8UW
+44 (0)24 76 523708 email: email@example.com
PR92 PJD October 2007